Anonymous
Guest
Anonymous
Guest
What's the deal with Takeda receiving ZERO press coverage on Affymax kidney drug. What cut is Takeda getting out of this, I'm smelling a Sucampo, KOS, Cephalon, Lilly, Shire, co promote disaster waiting to happen!
http://www.bloomberg.com/news/2012-...al-of-drug-for-anemic-kidney-patients-1-.html
http://www.bloomberg.com/news/2012-...al-of-drug-for-anemic-kidney-patients-1-.html